The chance observation that a patient with methylmalonic acidaemia (W) improved clinically and biochemically with amoxycillin given for a chest infection led to speculation about the contributory role of volatile fatty acids (VFA) produced by faecal bacteria. Response to amoxycillin was not sustained, and metronidazole was selected for further study, being active against anaerobes, which are the major producers of VFA's. Urinary methylmalonic acid (MM) and stool propionate, a precursor of MM were estimated over a period of 40 days before and 90 days during metronidazole treatment (11 mg/kg). Urinary MM fell froom 12.8 mole/mole creatinine (SD 4.21 n=17) to 3.5 (SD 1.5 n=15), p < 0.001 . Stool propionate fell from 101 !.Imole/ml stool (SD 5.3 n =13), to 2.1 (SD 6.8 n=23), p < 0.M)l. Neomycin had previously been shown to improve metaholic control in MMA. This is the first study correlating stool propionate and urine methylmalonate excretion in response to antibiotics in W. The faecal flora may contribute up to 70% of the substrate for propionate metabolism. This suggests a previously largely unexplored metaholic role for the intestinal flora and a novel avenue of therapy for MMA.
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BSERVATlONS ON LlPOSOME SUBSTITUTION IN PREIERM NFANTS WITH RESPIRATORY DISTRESS SYNDROME (RDS)
. 
This study was performed to flnd out whether the relation between transcutaneous oxygen tension (tcP02) and arterial oxygen tension (Pa02) changed with increasing gestational and postnatal age.
160 simultaneous measurements of tcPO2 and Pa02 were made at weekly intervals on 42 babies born at 24-41 weeks of gestation and aged 0-32 weeks from birth. tcP02 was measured using a Drzger Transoxode tcPO2 electrode set at 44'C and connected to a chart recorder. Arterial blood samples were obtained with minimal disturbance of the baby as judged by the sfability of the tcPO2 record. Pa02 was measured using an IL 1303 blood gas analyser.
At 0-1 week of postnatal age, mean tcPO2/Pa02 in 15 babies born at <30 weeks of gestation was 1.11 * SD 0.11, 11.19, and in 1 1 bables of 930 weeks of gestation it was 1.02 2 0.09, n-13 in.s.1. The tendency towards higher values for tcPO2/Pa02 in less mature babies persisted during the succeeding weeks but was not statistically significant. Irrespective of gestation, a progressive underestimate of Pa;)2 by tcPO2 with increasing postnalhl age was found. For. example, mean tcPO2/Pa02 from observations on 16 babies 18 weeks old was 0.83 2 0.15, n.72, significantly lower than in 36 babies <8 weeks old, 1.00 t 0.13, n=88 ip<0.001). We conclude that (11 tCP02 underestimated Pa02 with increasing postnatal age and (2) Pulmonary functions were evaluated in 12 preterm neonates with Brcnchopulmonary Dysplasia (BPD) before and during administration of Miox in order to study the effect of reduced turbulence associated with a low density gas mixture. Mean gestational age and birth weight were 28.52.60 SEMweeks and 970280 SEMgrams, respectively. The infants were studied at a mean age of 57.3210 SEX days, weight of 1980?220 SEM grams, and the inspired oxygen concentration ranged from 21-33%. Allneonates were spontaneously breathing and symptomatic of BPD characterized by tachypnea, retractions, radiographic alterations and the need for supplemental oxygen. Control (meant SEMI pulmonary function data were: frequency (f)=60.5?3.3bth/M; tidal volume (V~)=8.4?1.0ml/kg; pulmonary resistance (RL)=3.49t. 33cmH20/L/M; minute ventilation (MV)=504.6268ml/ M/kg; resistive work of breathing (WOB)=.102?.02kg/cm/kg; and mechanical power of breathing (POB)=5.392.65kgcm/kg/M. During Heliox breathing, there was a significant decrease in RL (A30%; p<.0025), WOB (A53%; p< .025), and POD (A40%; p<.0025) while f, VT, MV, and CL remained mchanged. Utilizing this data it was predicted that the oxygen cost of breathing decreased by .26?.05 SEMml/M/kg resulting in a caloric savings of 1.87t .36 SEMkcal/kg/day while breathing Heliox. These data indicate that in this population, ventilation is maintained while demands on respiratory muscles are decreased during Heliox breathing. Consequently, this modality may reduce respiratory muscle fatigue and caloric requirements for breathing, thus provide additional calories for growth and recovery. TcPC4monitoring is widely used in the neonatal ICU. Reliability anc afety of this indirect method to measure arterial PCO,(P~C~) have beer uestioned, particularly when the sensor remains in place for more thar hours. Goal of this study was to assess correlation between tcPC&anr aC0,and skin alterations during 24 hours monitoring without replaceent. Patients: 51 critically ill newborns who required an arterial atheter for the clinical management. Weights 680-4170 g, Gestational ges 27-41 weeks. Method: An iridium oxide electrode (Transcapnode ellige) heated at 4Z°C was chosen because of better stability than onventional glass electrodes. The sensor was calibrated with 5 and 10% 0,and attached to the trunc or to the thigh. TcPC&was recorded contiuously. Arterial blood samples were drawn systematically at 30' and at 4 hours and on clinical indications. PaC4was measured with an IL 313 r an AWL 945 gas analyser. Results: After removal of the sensor no isible change of the skin was noted in 44 infants and a discrete erytema in 7. A blister developed in one patient 24 hours later which disppeared without scar. The correlation of tcPC4 (y;Torr) vs. PaCO, (x; orr) was calculated for SO4 paired values: y = 5.4 + 1.4~; rz.89; =6.0 Torr. There was no systematic difference between the paired glues at 30' and those at 24 hours. The transcutaneous sensor detected 1% of hypocapnia (PaC0,<30 Torr, n=38) and 88% of hypercapnia PaCO,>50 orr, n.73).
Conclusion: The correlation between t~P C o~( 4 2~~) and PaCO, s acceptabel for clinical use and not influenced by the duration of ixation of the sensor up to 24 hours.
